KAS
ANIX icon

Kestra Advisory Services’s Anixa Biosciences ANIX Stock Holding History

Kestra Advisory Services’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
38,000
-13,000
-25% -$36.2K ﹤0.01% 3177
2026
Q1 		$132K Buy
51,000
+25,000
+96% +$74K ﹤0.01% 2999
2025
Q4 		$81.1K Buy
26,000
+2,000
+8% +$8.19K ﹤0.01% 3591
2025
Q3 		$79.2K Buy
24,000
+7,000
+41% +$22.1K ﹤0.01% 2833
2025
Q2 		$56.1K Sell
17,000
-29,000
-63% -$82.9K ﹤0.01% 2766
2025
Q1 		$132K Buy
46,000
+18,000
+64% +$51.5K ﹤0.01% 2556
2024
Q4 		$65K Buy
+28,000
New +$86.9K ﹤0.01% 2596

Other funds holding ANIX

DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return

Kestra Advisory Services's ANIX Position: Q2 2026 in Review

Kestra Advisory Services reduced its Anixa Biosciences (ANIX) stake by 25% in Q2 2026, selling an estimated $36.2K and leaving 38,000 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Kestra Advisory Services first reported a position in ANIX in Q4 2024 and has held it in 7 quarters since. The position peaked at $132K in Q1 2026. 26 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Kestra Advisory Services held 38,000 shares of Anixa Biosciences worth $106K as of Q2 2026.
  • Kestra Advisory Services sold 13,000 Anixa Biosciences shares in Q2 2026, an estimated $36.2K.
  • Anixa Biosciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3177 holding.
  • Kestra Advisory Services first reported a position in Anixa Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Kestra Advisory Services's Anixa Biosciences position peaked at $132K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.